A lethal complication of propofol

Asian Cardiovascular and Thoracic Annals

Volumn 14, Issue 1, 2006, Pages 60-62

  Suen, Hon Chi ^a,b   Haake, Robert J ^a   Chavez, Victor M ^a   Hayat, Sultan A ^a  

^a Memorial Hospital   (United States)

^b Cardiothoracic Surgery Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CREATINE KINASE MB; DANTROLENE; DIURETIC AGENT; LACTIC ACID; PROPOFOL;

ACUTE KIDNEY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; AUTOPSY; BRADYCARDIA; CARDIOMEGALY; CARDIOVERSION; CASE REPORT; DRUG FATALITY; DRUG MEGADOSE; EXTUBATION; FATTY LIVER; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEPATOMEGALY; HUMAN; HYPERKALEMIA; HYPERPLASIA; INTENSIVE CARE UNIT; INTUBATION; LUNG ALVEOLUS; MALE; MALIGNANT HYPERTHERMIA; METABOLIC ACIDOSIS; POSTOPERATIVE PERIOD; QRS COMPLEX; RESPIRATORY FAILURE; RESUSCITATION; RHABDOMYOLYSIS; SHOCK; SPLENOMEGALY; ST SEGMENT ELEVATION; THORACOTOMY; THORAX RADIOGRAPHY;

EID: 33644536732     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/021849230601400115     Document Type: Article

References (16)

1. Parke TJ, Stevens JE, Rice AS, Greenaway CL, Bray RJ, Smith PJ, et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992;305:613-6.
2. Barclay K, Williams AJ, Major E. Propofol infusion in children. BMJ 1992;305:953-4.
3. Bray RJ. Fatal myocardial failure associated with a propofol infusion in a child. Anaesthesia 1995;50:94.
4. Strickland RA, Murray MJ. Fatal metabolic acidosis in a pediatric patient receiving an infusion of propofol in the intensive care unit: Is there a relationship? Crit Care Med 1995;23:405-9.
5. Plotz FB, Waalkens HJ, Verkade HJ, Strengers JL, Knoester H, Mandema JM. Fatal side-effects of continuous propofol infusion in children may be related to malignant hyperthermia. Anaesth Intensive Care 1996;24:724.
6. Cray SH, Robinson BH, Cox PN. Lactic acidemia and bradyarrhythmia in a child sedated with propofol. Crit Care Med 1998;26:2087-92.
7. Hanna JP, Ramundo ML. Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children. Neurology 1998;50:301-3.
8. Perrier ND, Baerga-Varela Y, Murray MJ. Death related to propofol use in an adult patient. Crit Care Med 2000;28:3071-4.
9. Stelow EB, Johari VP, Smith SA, Crosson JT, Apple FS. Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings. Clin Chem 2000;46:577-81.
10. Cremer OL, Moons KG, Bouman EA, Kruijswijk JE, de Smet AM, Kalkman CJ. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet 2001;357:117-8.
11. Kelly DF. Propofol-infusion syndrome. J Neurosurg 2001;95:925-6.
12. Mathews EL, Dhamee MS. Propofol in patients susceptible to malignant hyperthermia: a case report and review of the literature. J Clin Anesth 1992;4:331-2.
13. McKenzie AJ, Couchman KG, Pollock N. Propofol is a "safe" anesthetic agent in malignant hyperthermia susceptible patients. Anaesth Intensive Care 1992;20:165-8.
14. Fruen BR, Mickelson JR, Roghair TJ, Litterer LA, Louis CF. Effects of propofol on Ca2+ regulation by malignant hyperthermia-susceptible muscle membranes. Anesthesiology 1995;82:1274-82.
15. Okamoto MP, Kawaguchi DL, Amin AN. Evaluation of propofol infusion syndrome in pediatric intensive care. Am J Health Syst Pharm 2003;60:2007-14.
16. Kang TM. Propofol infusion syndrome in critically ill patients. Ann Pharmacother 2002;36:1453-6.